|
•March 5.Public Health Advisory: Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings. Information
• February 25. FDA takes new regulatory action against Ranbaxy’s Paonta Sahib plant in India. FDA News
• February 23 Information for Healthcare Professionals for Zonisamide. Information
• February 19. FDA issues Updated Safety Information about Raptiva (efalizumab). Information
• February 9. FDA to meet with drug companies about REMS for certain opioid drugs. Information
• February 4. FDA issues an Early Communication about an Ongoing Safety Review Xigris (Drotrecogin alfa [activated]) Drug Information
Previous News Items |
